Form 4: Lemaitre Vascular Director Exercises Stock Options

Director John James O'Connor exercised stock options to acquire 7,500 shares of Lemaitre Vascular Inc. common stock.

Summary

• John James O'Connor, a director at Lemaitre Vascular Inc., exercised stock options on November 25, 2024.
• This transaction involved the acquisition of 7,500 shares of common stock at a price of $35.48 per share.
• The options were part of a grant that vested over three years, starting on December 20, 2019.
• Following the transaction, O'Connor directly owns 56,663 shares of Lemaitre Vascular Inc. common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, which is generally neutral to positive. The exercise of options by a director can be seen as a sign of confidence in the company.

Positives

• The exercise of options by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine transaction for a company with stock options as part of its compensation structure. It is common for directors to exercise options as they vest.

Comparison to Industry Standards

• Stock option grants and exercises are a common practice in publicly traded companies, particularly in the technology and healthcare sectors, where Lemaitre Vascular operates.
• The vesting schedule of three years is also a typical timeframe for such grants.
• The exercise price of $35.48 is specific to the company's stock performance at the time of the grant and exercise.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates director confidence.
• The transaction has no direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

stock options, insider trading, share acquisition, Lemaitre Vascular, director, LMAT